Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02759861 · ClinicalTrials.gov registry record · Phase 4
Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics
A Phase 4 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02759861 is a Phase 4 study that has completed, run by University of Nebraska. The registered enrollment target is 16 participants.
The verdict
NCT02759861, a Phase 4 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
To determine the efficacy and safety of Harvoni in treatment-naïve alcoholic subjects with Genotype 1 HCV infection
Interventions
- DRUG harvoni
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2020-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02759861
The ClinicalTrials.gov registry entry for NCT02759861 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which harvoni is the first listed.
NCT02759861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02759861 about?
NCT02759861 is a clinical study titled "Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics". To determine the efficacy and safety of Harvoni in treatment-naïve alcoholic subjects with Genotype 1 HCV infection
What is the current status of trial NCT02759861?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2016-08-01. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT02759861?
The interventions under investigation include: harvoni (DRUG).
Who is sponsoring clinical trial NCT02759861?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.